After search, choose a molecule or a kind of categories listed in the left to narrow down your filter. If you have any problems, please contact us!

Quick Order

VEGF121 / VEGF-A Antibody, Rabbit PAb

DatasheetReviewsRelated ProductsProtocols
Human VEGF-A Antibody Product Information
Immunogen:Recombinant Human VEGF121 / VEGF-A protein (Catalog#10008-HNAB)
Clone ID:
Ig Type:Rabbit IgG
Concentration:
Formulation:0.2 μm filtered solution in PBS with 5% trehalose
Preparation:Produced in rabbits immunized with purified, recombinant Human VEGF121 / VEGF-A (rh VEGF121 / VEGF-A; Catalog#10008-HNAB; P15692-9; Met 1-Arg 147). Total IgG was purified by Protein A affinity chromatography.
Human VEGF-A Antibody Usage Guide
Specificity:Human VEGF121 / VEGF-A
Application:ELISA

ELISA: 0.5-1 μg/mL

This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human VEGF121. The detection limit for Human VEGF121 is approximately 0.00975 ng/well.

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Other VEGF-A Antibody Products
Reactivity: Human  
Application: B/N  
  • Slide 1
11066-R010-500
11066-R010-200
500 µg 
200 µg 
Add to Cart
Reactivity: Human  
Application: B/N  
  • Slide 1
11066-R012-500
11066-R012-200
500 µg 
200 µg 
Add to Cart
Reactivity: Human  
Application: WB  IP  
  • Slide 1
  • Slide 1
100253-T36-200
100253-T36-100
100253-T36-50
200 µg 
100 µg 
50 µg 
Add to Cart
Reactivity: Human  
Application: ELISA  
    11066-T16-50
    11066-T16-100
    11066-T16-200
    50 µg 
    100 µg 
    200 µg 
    Add to Cart
    Reactivity: Human  
    Application: ELISA  
      11066-RP01-100
      11066-RP01-200
      11066-RP01-400
      100 µg 
      200 µg 
       
      Add to Cart
      Reactivity: Human  
      Application: ELISA  
        11066-RP02-50
        11066-RP02-100
        11066-RP02-200
        50 µg 
        100 µg 
        200 µg 
        Add to Cart
        Reactivity: Human  
        Application: ELISA  WB  IHC-P  
        • Slide 1
        • Slide 1
        10009-RP02-50
        10009-RP02-100
        10009-RP02-200
        50 µg 
        100 µg 
        200 µg 
        Add to Cart
        Reactivity: Human  
        Application: ELISA  
          10008-RP02-50
          10008-RP02-100
          10008-RP02-200
          50 µg 
          100 µg 
          200 µg 
          Add to Cart
          Reactivity: Human  
          Application: ELISA  
            11066-R105-50
            11066-R105-100
            50 µg 
            100 µg 
            Add to Cart
            Reactivity: Human  
            Application: ELISA  
              10008-R064-50
              10008-R064-100
              50 µg 
              100 µg 
              Add to Cart
              Reactivity: Human  
              Application: ELISA  
                10009-RP01-100
                10009-RP01-200
                10009-RP01-400
                100 µg 
                200 µg 
                 
                Add to Cart
                Reactivity: Mouse  
                Application: ELISA  
                  50159-RP01-100
                  50159-RP01-200
                  50159-RP01-400
                  100 µg 
                  200 µg 
                   
                  Add to Cart
                  Reactivity: Mouse  
                  Application: ELISA  
                    50159-T16-50
                    50159-T16-200
                    50159-T16-100
                    50 µg 
                    200 µg 
                    100 µg 
                    Add to Cart
                    Reactivity: Rat  
                    Application: ELISA  
                      80006-R003-100
                      80006-R003-50
                      100 µg 
                      50 µg 
                      Add to Cart
                      Reactivity: Rat  
                      Application: ELISA  
                        80006-T16-50
                        80006-T16-100
                        80006-T16-200
                        50 µg 
                        100 µg 
                        200 µg 
                        Add to Cart
                        Reactivity: Rat  
                        Application: ELISA  
                          80006-RP01-200
                          80006-RP01-400
                          80006-RP01-100
                          200 µg 
                           
                          100 µg 
                          Add to Cart
                          VEGF/VEGFA/VEGF165 Background

                          Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.

                          Human VEGF/VEGFA/VEGF165 References
                        • Woolard J. et al. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64(21): 7822-7835.
                        • Jia SF, et al. (2008) VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells. J Exp Ther Oncol. 7(2): 89-97.
                        • Cimpean AM, et al. (2008) Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma. Rom J Morphol Embryol. 49(3): 303-8.
                        • Hamdollah Zadeh MA, et al. (2008) VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation. 15(7): 605-14.
                        • Eisenach PA, et al. (2010) MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src. J Cell Sci. 123(Pt 23):4182-4193.
                        • Claesson-Welsh L (2010) Gremlin: vexing VEGF receptor agonist. Blood. 116(18):3386-7.
                        • Product nameProduct name
                          Size / Price
                          Catalog: 10008-RP01-100
                          List Price: 
                          Price:      (You Save: )
                          Size:
                          100 µg
                          200 µg
                          Quantity:+-
                          AvailabilityIn Stock
                          Bulk Discount InquiryAdd to Cart
                          All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
                          Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"